Plantiga Unveils Arc5
A Breakthrough in Wearable Technology for Health Practitioners and Elite Sports Teams
Vancouver, BC - Plantiga, world-leading smart insole and movement analytics company, is proud to announce the official launch of Arc5, the highly anticipated fifth iteration of their groundbreaking hardware and software platform. After four years of meticulous development and over 400 installations across academia, military, research, sports (NBA, MLB, MLS, NFL, NHL, NCAA) and clinical sectors, Arc5 represents a significant leap forward in movement data collection. This revolutionary product redefines the wearable technology category, enabling health practitioners and professional and college sports teams to unlock valuable insights into human movement and performance.
Arc5 is Accelerometry for Researchers and Clinicians. It has the ability to collect lab-quality movement data in any environment for up to 12 hours. This breakthrough technology allows in-depth analysis of movement patterns without cameras, cables, or additional sensors that impede natural movement. Whether embedded in an insole, orthotic or shoe, Arc5 excels in three key areas:
Precise Movement Analysis: Arc5 measures stride-by-stride movement asymmetries and step-by-step load throughout the day, offering data quality validated to gold standard tools. Plantiga and the Arc5 platform enable health practitioners and sports teams to comprehensively understand individual movement patterns.
Seamless Data Collection: With its advanced machine learning and AI models, Arc5 automatically detects walking, running, and jumping, providing a seamless and unobtrusive data collection experience. This eliminates the need for manual input and ensures accurate and reliable data for analysis.
Comprehensive Analysis and Insights: Upon data upload, Arc5 analyzes trends over time on various metrics, extracts gait features, offers additional insights, and empowers health practitioners and sports teams to uncover valuable information about movement patterns and their impact on health and performance.
"We are bringing the lab to the person," says Quin Sandler, CEO and co-founder of Plantiga. "Where wrist-worn devices and mobile phones fall short, Arc5 emerges as a paradigm-shifting wearable product. We aim to help athletes get healthy, stay healthy, and perform at their best. Arc5 caters to the needs of athletes and the professionals who support them, including physical therapists, athletic trainers, coaches, and sports scientists."
In conjunction with the product launch, Plantiga is expanding its sales efforts beyond North America. The availability of Arc5 will extend to Europe, Australia/New Zealand, Latin America, and the Middle East, facilitating the global adoption of this groundbreaking technology.
To further enhance their commitment to advancing health and performance, Plantiga is thrilled to announce the appointment of Dr. Selene Parekh, MD, MBA, as Chief Medical Officer. “Plantiga is pushing the boundaries of movement health, and not just within athletics,” says Parekh. “We live in an age of technology and Plantiga is making it more accessible for individuals to understand their own bodies. Better outcomes are possible for people with orthopedic, neurologic, and traumatic injuries and conditions.” Parekh, a renowned sports medicine foot and ankle surgeon at Rothman Orthopaedics, brings invaluable expertise and insights to Plantiga's mission of revolutionizing wearable technology.
Plantiga is pleased to announce that Arc5 will begin shipping worldwide on May 30th, coinciding with the American College of Sports Medicine Annual Meeting and World Congresses, where Plantiga is featured in several studies demonstrating its accuracy for the real-world monitoring of running biomechanics. This milestone marks a significant step forward in Plantiga's vision of providing innovative solutions to the healthcare and sports industries.
To learn more about Arc5 and Plantiga's cutting-edge technology, visit plantiga.com, connect with Quin on LinkedIn, or email press@plantiga.com.